Phase II Trial of Gemcitabine and Docetaxel with Bevacizumab in Soft Tissue Sarcoma

Figure 4

Duration on study for each patient treated with gemcitabine + docetaxel + bevacizumab. Patients marked by stars discontinued treatment on study because of good response and elected to have surgery.